Internalin A (InIA), a cell wall-bound protein of Listeria monocytogenes, is among the major components involved in the adhesion to and invasion of host cells expressing specific forms ofE-cadherin. Some L. monocytogenes strains secrete truncated non-functional forms orInlA. The purpose of this study is to compare the biofilm-forming abilities of L. monocytogenes strains from clinical sources expressing InlA proteins in the different forms. A total of 70 L. monocytogenes strains were examined using SDS-PAGE, Western blot, DNA sequencing, and microtitre plate biofilm formation assays. We found that 8 of the 70 strains expressed truncated InIA, and that this group of strains exhibited significantly enhanced biofilm-forming ability compared to the group expressing full-length InIA. Further experiments showed that: (i) L. monocytogenes biofilms were detached by treatment with protease K; (ii) protein fragments resulting from proteolysis, rather than intact proteins, are responsible for biofilm enhancement, because biofilm formation was impaired by the protease inhibitor a2-macroglobulin; (iii) truncated and/or proteolytically cleaved InlA are likely involved in the biofilm enhancement, based on the effects that anti-InlA monoclonal antibodies produced on the biofilm formation of L. monocytogenes strains expressing either truncated or full-length InIA. These data provide a basis for further investigation of the molecular structure and composition of L. monocytogenes biofilms.
Listeria monocytogenes is a foodborne pathogen that can potentially cause life-threatening systemic infection in high-risk individuals and gastroenteritis in healthy persons (1) . Its internalization at the intestinal level is promoted by internalin A (InIA), an 80 kDa cell-wall anchored protein (2) . Truncated non-functional InlA forms of molecular weights ranging from 43 kDa to 70 kDa which lack the cell wall anchoring motif are secreted by some L. monocytogenes strains that show reduced in vivo and in vitro adhesion and invasion abilities (3) (4) (5) (6) .
Expression of truncated InlA forms results from nonsense mutations in the inlA encoding gene that lead to premature stop codons: to date, a number of different inlA nonsense mutations have been identified (Table I) . They have always been associated with L. monocytogenes strains of serotype lI2c and less frequently with strains of serotype lI2a; on the other hand, nonsense mutations have never been detected in the inlA gene of L. monocytogenes strains of serotype 4b, and rarely in strains of serotype lI2b. Serotype lI2c and lI2a strains primarily belong to the phylogenetic lineage II and are prevalent in food and the environment, although they are only occasionally associated with human listeriosis; serotype 4b and 1/2b strains predominantly belong to the phylogenetic lineage I and account for most human clinical cases (7) . L. monocytogenes of different serotypes and/or lineages can vary in several other aspects, including their ability to develop biofilms. For instance, L. monocytogenes strains of serotype 1/2c have been reported to possess a higher biofilm-forming ability compared to the other serotypes (8) (9) (10) ; furthermore, some authors have shown that L. monocytogenes lineage II strains are better biofilm formers than lineage I strains (11) , although opposite results have been reported in earlier studies (12) .
Little is known on the biofilm-forming abilities ofL. monocytogenes strains expressing InlA proteins in the different forms. The aim of the present study is therefore to evaluate the biofilm formation of L. monocytogenes isolates expressing either full-length or truncated InlA. Since considerable information is available on the biofilm production by L. monocytogenes food and environmental isolates, because of the significance of microbial persistence in the food industry, we selected L. monocytogenes isolates from clinical sources in order to determine whether and the extent to which they are capable of producing biofilm.
MATERIALS AND METHODS

Bacterial isolates
A total of 70 L. monocytogenes strains of serotypes lI2a (n = 18), lI2b (n = 17), lI2c (n = 7), and 4b (n = 28) were analyzed in this study. Sixty-six strains were from the Listeria culture collection of the Istituto Superiore di Sanita (ISS): all strains isolated in Italy before 2004 from unlinked cases of human listeriosis and whose serotype had been determined were selected. Of these, 3 strains were from different outbreaks, two of which of gastroenteritis (13) (14) , 62 strains were from sporadic cases of listeriosis, and one strain had been isolated from the faeces of a healthy person. Four additional L. monocytogenes strains were from as many outbreaks of gastroenteritis which occurred in the US (15), Denmark (16) , Canada (17) , and Sweden (18), respectively. The latter strains were kind gifts from: B. Swaminathan, CDC, Atlanta, GA, USA; P. Gerner-Smidt, Statens Serum Institut, Copenhagen, Denmark; J. Farber, Health Canada, Ottawa, Canada; and W. Tham, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Some strains with well-characterized InlA protein and inlA gene were used as references: specifically, strain EGD-e (BUG600) of serotype 1/2a and strain ScottA of serotype 4b were used as controls for full-length InIA; strain L028 of serotype 1/2c, known to secrete a 63 kDa InlA (3), was used as a control for truncated InIA; strain EGDLlinlAB (BUG949), deleted of the inlA and inlB genes (19) , was included as a negative control. Strains L028, BUG600 and BUG949 were kindly provided by P. Cossart, Institut Pasteur, Paris, France.
All Listeria strains were stored at -80°C in microbank cryogenic vials (Prolab Diagnostics, Austin, TX). Prior to use, they were cultured in Trypton Soy Broth (TSB) (Oxoid, Milan, Italy) at 37°C, and streaked on Oxford or Aloa agar plates (Oxoid).
Protein extraction, SDS-PAGE and Western blot analysis
Cell wall proteins and extracellular proteins were isolated as described by Olier et al. (5) , with slight modifications. A single colony from each strain was selected from the agar plates and cultured in TSB at 37°C overnight. Bacteria were separated from the supernatants by centrifugation at 6000 X g for 10 min, at room temperature; both were then incubated with IX protease inhibitor cocktail (Roche Diagnostics, Milan, Italy) at 4°C for Ih, with shaking. Secreted proteins in the supernatants were precipitated by the addition of 16% (vi v) trichloroacetic acid (TCA) and incubation at 4°C overnight. Cell wall proteins were prepared by treatment ofthe bacterial pellets with lysis buffer (10 mM Tris-HCI, pH 8; 1% SDS); after 15 min incubation at room temperature, the Iysates were centrifuged, and the supernatants were collected, added with 16% (v/v) TCA, and incubated at 4°C overnight. Protein concentration in each extract was estimated by the BCA protein assay kit (Sigma-Aldrich, Milan, Italy). Amounts of 15-20 ug of each sample were mixed with equal volumes of Laemmli buffer 5X, boiled for 5 min, and loaded on 8% polyacrylamide gel. After electrophoresis (90 min at 100 V), the proteins were electroblotted to a nitrocellulose membrane (Amersham Biosciences, Milan, Italy) in a semidry system (Mini Protean II, Bio-Rad Laboratories, Milan, Italy). The membrane was then incubated for I h in 'Iris-buffered saline (TBS), pH 7.6, containing 5% bovine serum albumin (BSA) and 2% Tween 20. InlA was detected with either antiinternalin monoclonal antibodies (MAbs) 14.4 or G6.1 (20) , generous gifts of P. Cossart, Institut Pasteur, Paris, France. After reaction with peroxidase-conjugated goat anti-mouse secondary antibodies (Sigma-Aldrich), the bands of interest were visualized by measuring the peroxidase activity (ECL kit, Amersham Biosciences).
DNA sequencing
The inlA gene of the L. monocytogenes strains yielding InlA protein bands < 80 kDa in the Western blot analysis was partially sequenced. Genomic DNA was extracted from the bacterial cells using a DNA purification kit (Qiagen, Milan, Italy). The regions of the inlA gene to be amplified by PCR for sequencing were predicted according to the size observed for the truncated InlA proteins, and selected on the basis of the inlA gene sequence of strain EGD (GenBank accession no. NC_ 003210). The first region encompassed nucleotides 1240 to 1781 and was amplified using the primer pair: 5' GATCAAGCATGGACAAATGCA 3' (inIAl, forward) and 5' GCCGTAGGTTCTTGTAACAAG 3' (inlA2, reverse). The second region encompassing nucleotides 1691-2260 was amplified by the primer pair: 5' GTATTAACAGCTACACAGCAAC 3' (inlA3, forward) and 5' TTGTACTTGTTGTGCTGGCTG 3' (inlA4, reverse). The PCR reactions contained 20 ng genomic DNA, 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 2 mM MgC1 2 , 0.2 mM of each deoxyribonucleoside triphosphates (Amersham Biosciences), 0.5 flM primers, and 1.25 U of Taq-polymerase (Applied Biosystems, Foster City, CA, USA). The thermal cycling conditions were as follows: initial denaturation at 95°C for 10 min, followed by 35 cycles of 95°C for 1 min, 50°C for 1 min, noc for 1 min, and a final extension at noc for 10 min.
All PCR amplifications were performed in a programmable thermal cycler (MJ. Research, model PTC100, Waltham, MA, USA). PCR products were gel-purified (DNA gel extraction kit, Millipore Corporation, Bedford, MA, USA) and sent to MWG-Biotech (Ebersberg, Germany) for sequencing. The nucleotide sequences were determined on both DNA strands. The obtained consensus sequences were deposited in the GenBank database under accession numbers EV131779 to EVI31786. They were compared to the inlA gene sequence of strain EGD (accession no. NC_00321 0).
Micro titre plate biofilm assays
Biofilm formation of the 1. monocytogenes strains was assessed by the method ofDjordjevic et al. (12) modified as described by Borucki et al. (11) . Briefly, a 1:40 dilution of overnight cultures in Modified Welshimer's broth (MWB) (21) was used to inoculate wells of polyvinylchloride (PVC) microtitre plates (Becton Dickinson, Milan, Italy). After 40 h growth at 32°C, the plates were washed three times with sterile water. The adherent bacterial film was fixed by air drying and then stained with a 0.1% crystal violet (CV) solution for 45 min; excess stain was then removed by washing with sterile water. After air drying, 200 III of 95% ethanol were added to each well, and the optical densities (Ofr) were measured at 595 nm in a microplate spectrophotometer reader (model 550? Bio-Rad Laboratories). Crystal violet binding to wells exposed only to the medium with no bacteria served as blank. 1. monocytogenes strains were classified as strong, moderate, weak, and no biofilm producers according to the method described by Stepanovic et al. (22) .
A microtitre plate biofilm detachment assay (23) was carried out by following the same experimental procedure described above, except for treatment of the bacterial biofilms in each well with 100 III of protease K (1 mg/ml in 20 mM Tris, pH 7.5, 100 mM NaCl) for 3 h at 37°C, prior to CV staining.
Selected L. monocytogenes strains were subjected to a specific biofilm inhibition experiment, employing the broad-range protease inhibitor a2-macroglobulin (23) . Different concentrations of the inhibitor (0.125 to 0.5 V/ ml a2-macroglobulin) were added to the MWB medium before strain inoculation, and the biofilm formation was assayed as detailed above. Heat-inactivated a2macroglobulin was used to control the specificity of biofilm inhibition. In another experiment, the biofilm formation of selected 1. monocytogenes strains was measured in the presence of different concentrations (0.2 and 1 ug/ml) of either anti-internal in MAb 14.4 or G6.1.
All microtitre plate biofilm assays were performed at least three times, with 6 replicates for each strain per assay.
Statistical analyses
One-way analysis of variance (ANOVA) and the Tukey's multiple comparisons test were used to evaluate differences between means for each strain. The Student's t test was applied when two groups of strains were compared. All calculations were performed with GraphPad Prism version 4 software (GraphPad Software, San Diego, CA) and p values < 0.05 were considered significant.
RESULTS
Western blot analysis ofprotein extracts
The Western blot analysis was performed on both cell wall extracts and extracellular protein extracts. The majority of the 70 L. monocytogenes strains tested in this study expressed full-length InIA: in fact, a band that comigrated with the 80 kDa full-length InlA of the control strains EGDe and ScottA was revealed in the protein extracts of 62 L. monocytogenes strains, which comprised all serotype lI2b and 4b strains and most serotype lI2a strains. Among these were included all of the outbreak-related and the gastroenteric strains included in this study, as well as a strain isolated from a healthy carrier. 
II at position 12 3 I Representative strains first described to harbour the specific nucleotide mutation. 2Position numbers refer to the inlA gene ofL. monocytogenes strain EGD (GenBank accession number NC_003210) "Translation of the mutated inlA gene from a potential start codon downstream of the deletion has been hypothesized (36) Eight L. monocytogenes strains (11.4% of the total 70 tested in this study) expressed truncated InlA. Specifically, a band that comigrated with the 63 kDa truncated InlA of the control strain L028 (3) was observed in the proteins isolated from serotype 1/2c strains 314 and 1327. Five additional strains of serotype 1/2c (268, 269, 270, 1107, 1326) expressed an InlA variant whose size (approximately 68 kDa) was intermediate between full-length InlA and the truncated InlA of strain L028. Serotype 1/2a strain 1036 produced an InlA with a molecular weight of about 47 kDa. Hence, a total of three different truncated InlA variants were identified (Fig. 1) , all in strains isolated from sporadic cases of invasive listeriosis.
Whereas higher amounts of full-length InlA were revealed in the cell wall protein extracts from the strains, the truncated InlA forms were mainly detected in the extracellular protein extracts, indicating that the truncated InlA variants probably lacked the carboxy-terminal cell wall anchoring motif (data not shown). As expected, no InlA band was detected in the protein extracts from strain BUG949 (EGD~inIAB).
Partial inlA gene sequencing
DNA sequencing of the inlA gene fragments amplified from the 8 L. monocytogenes strains that expressed the truncated InlA variants described above showed different nonsense mutations.
Specifically, a deletion of an adenine at position 1637 was detected in the inlA gene fragments obtained from strains 314 and 1327; this nonsense mutation has previously been reported in the inlA gene of strain L028 (3), and the resulting frameshift causes a premature stop codon in the coding sequence at position 1729 (Table I) .
A substitution of an adenine with a guanine at position 2053 creating a stop codon (TAG) was detected in the inlA gene fragments amplified from strains 268, 269, 270,1107,1326; a substitution ofa cytosine with a thymine at position 1474 producing a stop codon (TAG) was detected in the inlA gene fragment amplified from the strain 1036. Both nonsense mutations have already been described (Table I) (6) (7) (24) (25) .
The theoretical molecular weights ofthe truncated InlA proteins resulting from the nonsense mutations described above were consistent with the sizes of the InlA variants observed in the Western blot analysis: moreover, all three putative truncated InlA proteins lack the carboxy-terminal cell wall sorting region, in accordance with their greater detection in the extracellular protein extracts, compared to the cell wall extracts. Fig. 2 shows the mean OD 595 values after CV staining for all L. monocytogenes strains tested in a microtitre plate biofilm formation assay. Values of individual strains ranged from 0.1084 to 0.6465. The cut-off'Ofr.j, as defined by Stepanovic et al. (22) was 0.1318: accordingly, 3 strains were classified as no biofilm producers (OD 595 < 0.1318); 28 strains were classified as weak biofilm producers (0.1318 < OD595 0.2636); 38 strains were classified as moderate biofilm producers (0.2636 < OD 595~0 .5272); and 5 strains were classified as strong biofilm producers (OD 595 > 0.5272). Comparison among the different L. monocytogenes serotypes showed that the average OD595 value of serotype 1/2c strains was higher than the values of serotype 1/2a and 1/2b strains, and significantly higher than the average OD595 value of serotype 4b strains (p = 0.0015), respectively (Fig. 3a) . Furthermore, the mean OD 595 value for the group of L. monocytogenes strains producing truncated InlA was significantly higher than the mean OD 595 value for the group of strains expressing a full-length InlA (p = 0.0019) (Fig. 3b) .
Microtiter plate biofilm assays
To determine whether protein components are pre sent in the L. monocytogenes biofilms, we eva luated the sensitivity of the biofilms to treatment with protease K, based on the assumption that if the biofilm does not contain proteins it should be resistant to prot ease K treatment. Nine strains selected amon g those of different serotypes that showed a good ability to form biofilm s, including 3 repre sentative strains expressing each of the truncated InlA variants identified in this study, were assayed . The protease K remo ved 84% to 98% of the biofilms produced by the strains, regardless of the InlA form that they produced (Table II) .
Since the highest individual OD 595 values were displa yed by several L. mono cytogenes strains expressing full-length InlA (Fig. 2) , we investigated whether the biofilm formation by these strains was of some representative strains prior to assessing their biofilm formation. The results showed that a2 -macroglobulin inhibited the biofilm formation in both strains expressing full-length and truncated InIA, in a relatively dose-dependent manner; when a2-macroglobulin was heat-inactivated, its ability to inhibit the biofilms was lost (Fig. 4) . It can be concluded that protein fragments resulting from proteolysis increase the level of biofilm formation by L. monocytogenes. Whether full-length or truncated InlA are among the proteins involved in the biofilm enhancement wa s investigated by experiments comparing the effects of two different anti-lnlA monoclonal antibodies [MAbs 14.4 and G6.1 (20) ] on the biofilm formation by L. monocytogenes strains expressing different InlA variants. MAbs 14.4 and G6 .1, used at two different concentrations (I ug/ml and 0.2 ug/ml) , respectively cause d little or no effect on the biofilm formation of strain BUG949 (EGO~inlAB) (Fig . 5 ); since this strain does not express InlA because its inlA gene is deleted, the scarce biofilm inhibition observed with MAb 14.4 was regarded as a background interference, due to the inclusion of this MAb in the broth culture. The effects of the two MAbs on the biofilm formation of the wild-type strain BUG600 (EGO-e), a weak biofilm producer strain known to express a full-length InIA, were very simi lar to those observed with the mutant strain BUG949 (Fig . 5 ); in particular, although both MAbs reacted with the full-length InlA of strain BUG600, neither of them interfered with the biofilm formation of this strain.
By contrast, the moderate biofilm-forming ability of the other reference strain producing full-length InlA (i.e., strain ScottA) was significantly reduced by both MAbs, in a dose-dependent manner (Fig .  5) . Similarly, both MAbs significantly reduced the biofilm-fonning abilities of strains 269 and L028, which expressed two different truncated InlA variants (68 and 63 kOa, respectively) ( Fig. 5 ). These results are consistent with our previous observation that the increased biofilm formation of the stronger biofilm producer strains results from proteolysis, and supports that full-length InlA is presumably among the proteins subject to proteolysis. shortest InlA variant (47 kDa) (p < 0.001, with both MAb 14.4 concentrations); however, MAb G6.l significantly enhanced the biofilm formation by this strain (p < 0.001, with both MAb G6.l concentrations) ( Fig. 5 ). This could be explained by the fact that the two MAbs recognize diverse conformational epitopes of the LRR region of InlA (20) : it is thus possible that a specific interaction occurs between MAb G6.1 and the epitopes of the shortest InlA variant secreted by strain 1036, which ultimately enhances biofilm formation.
DISCUSSION
Eight of the 70 L. monocytogenes clinical strains tested in this study were found to express truncated InlA due to nonsense mutations in their inlA gene. In particular, three different inlA gene nonsense mutations leading to the expression of three truncated InlA variants were identified, all in L. monocytogenes strains of serotypes 1/2c (7/7 strains) and lI2a (1/18 strains). These results confirmed that L. monocytogenes strains with a non-functional truncated InlA maintain the ability to cause human infection (6, 26) .
The truncated InlA variants recognized in the present study, like all truncated InlA forms identified to date, retain the amino-terminal leucinerich-repeat (LRR) region of the protein, which is thought to playa role in protein-protein interaction, thus providing the LRR-containing proteins with adhesive properties (27) . Adhesion of bacteria to surfaces and biofilm formation are basic features in environmental adaptation and are also pertinent to bacterial infections, since the ability to form biofilms may enhance the ability of bacteria to infect the host (28) .
We thus compared information about the prevalence of truncated InlA among the clinical strains of L. monocytogenes to data on their biofilmforming abilities. Our results revealed that truncated InlA was associated with an increased ability to form biofilms. We hypothesized that truncated InlA, which is fully released in the extracellular medium, could become part of the biofilm matrix surrounding the L. monocytogenes cells.
This hypothesis is supported by several lines of evidence. First of all, the involvement of proteins in the initial adhesion of L. monocytogenes had previously been demonstrated by the fact that L. monocytogenes cells did not adhere to different supports in the presence of the proteolytic enzyme trypsin (29) ; in our study, we showed that protein components are also responsible for the maintenance of the biofilm, based on the removal of preformed mature biofilms by protease K, another proteolytic enzyme. Secondly, we demonstrated that proteolytically processed proteins are more likely to be part of the L. monocytogenes biofilms, given that biofilm formation was severely impaired by the protease inhibitor a2-macroglobulin. Proteases and products from the proteolysis of cell surface proteins have indeed been detected in the secretome of L. monocytogenes (30) ; thus, other cell surface and secreted proteins besides InlA may serve as substrates for proteolysis, and variation in the biofilm-forming abilities of L. monocytogenes strains may result from differences in their protease activity levels. Finally, the fact that the truncated and/or proteolytically cleaved InlA forms are likely involved in the enhancement of L. monocytogenes biofilm-forming ability was further supported by our results on the effects of anti-InlA MAbs on the biofilm formation of strains expressing the different InlA variants.
Evidence exists that a number ofbacterial surface proteins which play an important role in bacterial infections and contain repeat domains are adhesive to biotic and/or abiotic surfaces and thus contribute to biofilm development: examples include the biofilm-associated protein (Bap) of Staphylococcus aureus, the enterococcal surface protein (Esp) of Enterococcus faecalis, and the BapA protein of Salmonella enterica ser. enteritidis (31) . One such protein, the accumulation-associated protein (Aap) of Staphylococcus epidermidis, has been shown to be responsible for the induction ofbiofilm formation when it is proteolytically truncated (23) .
InlA is one of the 25 LRR-containing proteins (intemalins) produced by L. monocytogenes; some ofthese intemalins contain a repetitive domain (PKD repeats) which shows significant homology with adhesive proteins of other bacteria (32) , suggesting that these proteins may additionally function as adhesins in this species. Moreover, a protein similar to the recently recognized InlJ of L. monocytogenes (33) has been found to play a role in the biofilm formation of Porphyromonas gingivalis (34) .
Further work on the effect ofexpression ofInlA on the ability to form biofilms would require comparison of the biofilm fonnation ofL. monocytogenes strains expressing other different InlA variants, and genetic, proteomic or electron microscopy approaches. Finally, research on the exact role of biofilms in L. monocytogenes pathogenesis is warranted.
